Paper39268652
Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement.
Edgar JE and 1 other. Immunol Rev, 2024. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement. Papers, record 39268652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39268652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neutralizing | Major topic |
| Antibody-Dependent Enhancement | Major topic |
| Immunoglobulin Fc Fragments | Major topic |
| Receptors, IgG | Major topic |
| Animals | |
| Humans | |
| Antibodies, Monoclonal | |
| Antibodies, Viral | |
| Virus Diseases |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U19AI111825 | National Institute of Allergy and Infectious Diseases | U19AI111825 | PubMed and NIH | NIH RePORTER | |
| R01CA244327 | NCI NIH HHS | United States | R01CA244327 | PubMed and NIH | NIH RePORTER |
| R01 AI145870 | NIAID NIH HHS | United States | R01AI145870 | PubMed and NIH | NIH RePORTER |
| R01 AI137276 | NIAID NIH HHS | United States | R01AI137276 | PubMed and NIH | NIH RePORTER |
| R01AI145870 | National Institute of Allergy and Infectious Diseases | R01AI145870 | PubMed and NIH | NIH RePORTER | |
| U19 AI111825 | NIAID NIH HHS | United States | U19AI111825 | PubMed and NIH | NIH RePORTER |
| R01 CA244327 | NCI NIH HHS | United States | R01CA244327 | PubMed and NIH | NIH RePORTER |
| R01AI137276 | National Institute of Allergy and Infectious Diseases | R01AI137276 | PubMed and NIH | NIH RePORTER |
References289
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33972256 | Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/33972256 | PubMed |
| 2 | 26497511 | Mouse and human FcR effector functions. | Immunol Rev | 2015 | https://conductscience.org/library/papers/26497511 | PubMed |
| 3 | 28679958 | Fc functional antibodies in humans with severe H7N9 and seasonal influenza. | JCI Insight | 2017 | https://conductscience.org/library/papers/28679958 | PubMed |
| 4 | 17240489 | Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. | Vaccine | 2007 | https://conductscience.org/library/papers/17240489 | PubMed |
| 5 | 32209433 | Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding. | Structure | 2020 | https://conductscience.org/library/papers/32209433 | PubMed |
| 6 | 27354365 | Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge. | J Infect Dis | 2016 | https://conductscience.org/library/papers/27354365 | PubMed |
| 7 | 17704420 | FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17704420 | PubMed |
| 8 | 32540901 | Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. | Science | 2020 | https://conductscience.org/library/papers/32540901 | PubMed |
| 9 | 19841167 | Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. | J Immunol | 2009 | https://conductscience.org/library/papers/19841167 | PubMed |
| 10 | 22531445 | Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay. | MAbs | 2012 | https://conductscience.org/library/papers/22531445 | PubMed |
| 11 | 15466916 | The coordination of signaling during Fc receptor-mediated phagocytosis. | J Leukoc Biol | 2004 | https://conductscience.org/library/papers/15466916 | PubMed |
| 12 | 10403650 | SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. | Immunity | 1999 | https://conductscience.org/library/papers/10403650 | PubMed |
| 13 | 25215485 | Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. | Cell | 2014 | https://conductscience.org/library/papers/25215485 | PubMed |
| 14 | 1564451 | Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody. | J Med Virol | 1992 | https://conductscience.org/library/papers/1564451 | PubMed |
| 15 | 15043007 | Virus entry: molecular mechanisms and biomedical applications. | Nat Rev Microbiol | 2004 | https://conductscience.org/library/papers/15043007 | PubMed |
| 16 | 22908282 | Autonomous phagosomal degradation and antigen presentation in dendritic cells. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22908282 | PubMed |
| 17 | 14700166 | Clinical presentations of dengue hemorrhagic fever in infants compared to children. | J Med Assoc Thai | 2003 | https://conductscience.org/library/papers/14700166 | PubMed |
| 18 | 32525844 | Early safety indicators of COVID-19 convalescent plasma in 5000 patients. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32525844 | PubMed |
| 19 | 28812955 | IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody development. | MAbs | 2017 | https://conductscience.org/library/papers/28812955 | PubMed |
| 20 | 35690075 | Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/35690075 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42750812 | Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies. | iScience | 2026 | https://conductscience.org/library/papers/42750812 | PubMed |
| 42750060 | Mechanisms of antibody-dependent enhancement and its research progress in animal coronaviruses. | Vet Res | 2026 | https://conductscience.org/library/papers/42750060 | PubMed |
| 42639460 | Immunobridging Analysis of Pemivibart for the Treatment of COVID-19: A Therapeutic Gap for the Immune-Compromised Population Remains. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42639460 | PubMed |
| 42439638 | Distinct Innate and Adaptive Immune Modules Differentially Associate with HIV Reservoir Size and Decay During Early Antiretroviral Therapy. | Cells | 2026 | https://conductscience.org/library/papers/42439638 | PubMed |
| 42337147 | Clinical Manifestations and Immunological Impacts in Co-Infections and Sequential Infections of SARS-CoV-2 and Arboviruses. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42337147 | PubMed |
| 42327721 | Polyfunctional antibody signature defines protection in Andes hantavirus survival. | Front Immunol | 2026 | https://conductscience.org/library/papers/42327721 | PubMed |
| 42199422 | Fc effector functions in RNA viral infections: mechanisms of antiviral immunity and implications for vaccine design. | Front Immunol | 2026 | https://conductscience.org/library/papers/42199422 | PubMed |
| 42148106 | Determinants of success and failure of antibody-based strategies against respiratory viruses: insights from RSV and SARS-CoV-2. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148106 | PubMed |
| 41709436 | Antibody-Antibiotic Conjugates: Mechanisms, Clinical Progress, and Next-Generation Strategies Against Multidrug-Resistant Bacterial Infections. | Microbiologyopen | 2026 | https://conductscience.org/library/papers/41709436 | PubMed |
| 41149075 | The Yin and Yang of Antibodies in Viral Infectious Diseases. | Diseases | 2025 | https://conductscience.org/library/papers/41149075 | PubMed |
| 41136184 | Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort. | Gut | 2026 | https://conductscience.org/library/papers/41136184 | PubMed |
| 41012704 | Antibody-Dependent Enhancement of Porcine Reproductive and Respiratory Syndrome Virus Infection Antagonizes the Secretion of Type I Interferons in Porcine Alveolar Macrophages by Interfering with the Retinoic Acid-Inducible Gene I/Melanoma Differentiation-Associated Gene 5 Pathway via Fc Gamma Receptor I. | Viruses | 2025 | https://conductscience.org/library/papers/41012704 | PubMed |
| 40989107 | Reprogramming the tumor microenvironment: synergistic mechanisms of antibody-drug conjugates and immune checkpoint inhibitors. | Antib Ther | 2025 | https://conductscience.org/library/papers/40989107 | PubMed |
| 40591599 | FcγRIIIa is a noncanonical costimulatory molecule for CD8 T cells. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40591599 | PubMed |
| 40489867 | The hot spots and trends of Fc gamma receptor: A bibliometric analysis from 2004 to 2024. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/40489867 | PubMed |
| 40249965 | Maternal Antibodies to Neurovirulent Pathogens in Fetal Tissues. | Annu Rev Virol | 2025 | https://conductscience.org/library/papers/40249965 | PubMed |
| 40105005 | Autovaccination revisited: potential to boost antiviral immunity and facilitate HIV-1 cure/remission in children. | Curr Opin HIV AIDS | 2025 | https://conductscience.org/library/papers/40105005 | PubMed |
| 39268652 | Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement. | Immunol Rev | 2024 | https://conductscience.org/library/papers/39268652 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39268652
GET https://conductscience.org/api/papers/v1/39268652/references?page=2